The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors. It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase).
Arglabin reduces inflammation and plasma lipids, increases autophagy, and orients tissue macrophages into an anti-inflammatory phenotype in ApoE2.Ki mice fed a high-fat diet.
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | 2H-Bisoxireno[2,3:8,8a]azuleno[4,5-b]furan-7(3aH)-one,octahydro-3a,8c-dimethyl-6-methylene-, (1aR,2aR,3aS,5aS,8aS,8bS,8cS)- | 36416-50-9 | C15H18O4 | 262.306 |
| —— | 10α-chloro-1β-hydroxyarglabin | 139224-03-6 | C15H19ClO3 | 282.767 |
| —— | 1α-chloro-10β-hydroxyarglabin | 139224-04-7 | C15H19ClO3 | 282.767 |
| —— | 3α,10α-dichloro-1β,4β-dihydroxyarglabin | 139254-36-7 | C15H20Cl2O4 | 335.227 |
| —— | 4α,10α-dichloro-1β,3β-dihydroxyarglabin | 139254-37-8 | C15H20Cl2O4 | 335.227 |
| —— | 1α,13-dichloro-10β-hydroxyarglabin | 139224-05-8 | C15H20Cl2O3 | 319.228 |